Neurophage Pharmaceuticals
HomeAbout UsOur ScienceNewsCareersContact Us

04.22.14
NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer’s Disease and Other Neurodegenerative Disorders

. . . . . . . . . . . . . . . . . . . . . .

03.25.2014
Neurophage, Inc. Raises $17 Million In Series D Financing

. . . . . . . . . . . . . . . . . . . . . .

12.19.2013
NeuroPhage Awarded Second Grant from Michael J. Fox Foundation for Parkinson’s Disease Research

. . . . . . . . . . . . . . . . . . . . . .

12.03.2013
NeuroPhage to Participate in World's First G8 Dementia Summit

. . . . . . . . . . . . . . . . . . . . . .

05.06.2013
Neurophage, Inc. Raises $6.4 Million In Additional Financing

. . . . . . . . . . . . . . . . . . . . . .

 

 

© Neurophage Pharmaceuticals 2014

To advance the treatment of chronic neurodegenerative diseases through a novel, multi-target approach to reducing pathologic deposits of misfolded proteins.
Learn More About GAIM